DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
Toronto, Ontario
Lumira Ventures, Canada's largest life sciences venture capital firm, invests in healthcare innovators from early-stage to revenue-generating biotech, biotherapeutics, and medical devices. Headquartered in Toronto, Ontario.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Lumira Ventures IV (international), L.P. | 2022 | Active deployment | n/a | $12.3M | 0 |
| Lumira Ventures IV Holding LP | 2022 | Active deployment | n/a | $2.3M | 0 |
| Lumira Capital IV (international), L.P. | 2018 | Harvest | n/a | $4.2M | 0 |
| Lumira Capital IV GP, L.P. | 2018 | Harvest | n/a | $2.2M | 0 |
| Lumira Capital II (international) Limited Partnership | n/a | Unknown | n/a | $7.9M | 0 |
| Lumira Capital (USA) Limited Partnership | n/a | Unknown | n/a | $17,783 | 0 |
| Lumira Capital GP Limited Partnership | n/a | Unknown | n/a | $334,000 | 0 |
| Merck Lumira Biosciences Fund Limited Partnership | n/a | Unknown | n/a | $28.2M | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| Organiq Media | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Congruence | n/a | unknown | $39.5M | n/a | Unknown | Mar 19, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| Lumira Capital | Investissement Québec | 1 | 1 | Mar 19, 2026 | One time |
| Lumira Capital | Dimension Management, L.P. | 1 | 1 | Mar 19, 2026 | One time |
| Lumira Capital | Fstq | 1 | 1 | Mar 19, 2026 | One time |
| Driehaus | Lumira Capital | 1 | 1 | Mar 19, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Danielle Karakas (Analyst), Venture Fellows (Portfolio), Gerry Brunk (Managing Partner), Nikhil Thatte (Partner), Isabelle Harris (Associate), Dahlia Abbott (Accounting / Office Manager), Bella Giancotta (Communications & Operations Manager), Theodore Witek (Special Advisor), LU Han (Principal), Suman Rao (Principal), Jacki Jenuth (Principal And Coo), Beni Rovinski (Managing Director).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan